Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration.

Abstract:

INTRODUCTION:The longitudinal degradation mechanism of extracellular matrix (ECM) in the interbertebral disc remains unclear. Our objective was to elucidate catabolic and anabolic gene expression profiles and their balances in intervertebral disc degeneration using a static compression model. METHODS:Forty-eight 12-week-old male Sprague-Dawley rat tails were instrumented with an Ilizarov-type device with springs and loaded statically at 1.3 MPa for up to 56 days. Experimental loaded and distal-unloaded control discs were harvested and analyzed by real-time reverse transcription-polymerase chain reaction (PCR) messenger RNA quantification for catabolic genes [matrix metalloproteinase (MMP)-1a, MMP-2, MMP-3, MMP-7, MMP-9, MMP-13, a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-4, and ADAMTS-5], anti-catabolic genes [tissue inhibitor of metalloproteinases (TIMP)-1, TIMP-2, and TIMP-3], ECM genes [aggrecan-1, collagen type 1-α1, and collagen type 2-α1], and pro-inflammatory cytokine genes [tumor necrosis factor (TNF)-α, interleukin (IL)-1α, IL-1β, and IL-6]. Immunohistochemistry for MMP-3, ADAMTS-4, ADAMTS-5, TIMP-1, TIMP-2, and TIMP-3 was performed to assess their protein expression level and distribution. The presence of MMP- and aggrecanase-cleaved aggrecan neoepitopes was similarly investigated to evaluate aggrecanolytic activity. RESULTS:Quantitative PCR demonstrated up-regulation of all MMPs and ADAMTS-4 but not ADAMTS-5. TIMP-1 and TIMP-2 were almost unchanged while TIMP-3 was down-regulated. Down-regulation of aggrecan-1 and collagen type 2-α1 and up-regulation of collagen type 1-α1 were observed. Despite TNF-α elevation, ILs developed little to no up-regulation. Immunohistochemistry showed, in the nucleus pulposus, the percentage of immunopositive cells of MMP-cleaved aggrecan neoepitope increased from 7 through 56 days with increased MMP-3 and decreased TIMP-1 and TIMP-2 immunopositivity. The percentage of immunopositive cells of aggrecanase-cleaved aggrecan neoepitope increased at 7 and 28 days only with decreased TIMP-3 immunopositivity. In the annulus fibrosus, MMP-cleaved aggrecan neoepitope presented much the same expression pattern. Aggrecanase-cleaved aggrecan neoepitope increased at 7 and 28 days only with increased ADAMTS-4 and ADAMTS-5 immunopositivity. CONCLUSIONS:This rat tail sustained static compression model mimics ECM metabolic imbalances of MMPs, aggrecanases, and TIMPs in human degenerative discs. A dominant imbalance of MMP-3/TIMP-1 and TIMP-2 relative to ADAMTS-4 and ADAMTS-5/TIMP-3 signifies an advanced stage of intervertebral disc degeneration.

journal_name

Arthritis Res Ther

authors

Yurube T,Takada T,Suzuki T,Kakutani K,Maeno K,Doita M,Kurosaka M,Nishida K

doi

10.1186/ar3764

subject

Has Abstract

pub_date

2012-03-06 00:00:00

pages

R51

issue

2

eissn

1478-6354

issn

1478-6362

pii

ar3764

journal_volume

14

pub_type

杂志文章
  • Trends in physician diagnosed gout and gout therapies in the US: results from the national ambulatory health care surveys 1993 to 2009.

    abstract:INTRODUCTION:Gouty arthritis (gout) is primarily cared for in ambulatory care settings. Although the prevalence of gout in the US is thought to be increasing, there have been few data on this as well as temporal changes in gout medication use. METHODS:We analyzed annual visit and drug utilization data from national sa...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4370

    authors: Krishnan E,Chen L

    更新日期:2013-11-06 00:00:00

  • Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus.

    abstract:BACKGROUND:Plasmablasts and plasma cells play a key role in many autoimmune diseases, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). This study was undertaken to evaluate the potential of targeting CD38 as a plasma cell/plasmablast depletion mechanism by daratumumab in the treatment of patien...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-018-1578-z

    authors: Cole S,Walsh A,Yin X,Wechalekar MD,Smith MD,Proudman SM,Veale DJ,Fearon U,Pitzalis C,Humby F,Bombardieri M,Axel A,Adams H 3rd,Chiu C,Sharp M,Alvarez J,Anderson I,Madakamutil L,Nagpal S,Guo Y

    更新日期:2018-05-02 00:00:00

  • The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.

    abstract:BACKGROUND:Biologic disease-modifying antirheumatic drugs (bDMARDs) are important options for managing rheumatoid arthritis (RA). Once patients achieve disease control, clinicians may consider dose reduction or withdrawal of the bDMARD. Results from published studies indicate that some patients will maintain remission;...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-019-1937-4

    authors: Tanaka Y,Smolen JS,Jones H,Szumski A,Marshall L,Emery P

    更新日期:2019-07-05 00:00:00

  • Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patients.

    abstract:INTRODUCTION:Hyperuricemia is the greatest risk factor for gout and is caused by an overproduction and/or inefficient renal clearance of urate. The fractional renal clearance of urate (FCU, renal clearance of urate/renal clearance of creatinine) has been proposed as a tool to identify subjects who manifest inefficient ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/ar4020

    authors: Kannangara DR,Ramasamy SN,Indraratna PL,Stocker SL,Graham GG,Jones G,Portek I,Williams KM,Day RO

    更新日期:2012-08-17 00:00:00

  • Neural immune pathways and their connection to inflammatory diseases.

    abstract::Inflammation and inflammatory responses are modulated by a bidirectional communication between the neuroendocrine and immune system. Many lines of research have established the numerous routes by which the immune system and the central nervous system (CNS) communicate. The CNS signals the immune system through hormona...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/ar1002

    authors: Eskandari F,Webster JI,Sternberg EM

    更新日期:2003-01-01 00:00:00

  • Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study.

    abstract:INTRODUCTION:Cardiovascular disease (CVD) is the leading cause of death in patients with inflammatory polyarthritis (IP), especially in seropositive disease. In established rheumatoid arthritis (RA), insulin resistance (IR) is increased and associated with CVD. We investigated factors associated with IR in an inception...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3476

    authors: Mirjafari H,Farragher TM,Verstappen SM,Yates A,Bunn D,Marshall T,Lunt M,Symmons DP,Bruce IN

    更新日期:2011-01-01 00:00:00

  • Low-intensity pulsed ultrasound rescues insufficient salivary secretion in autoimmune sialadenitis.

    abstract:INTRODUCTION:Low-intensity pulsed ultrasound (LIPUS) has been known to promote bone healing by nonthermal effects. In recent studies, LIPUS has been shown to reduce inflammation in injured soft tissues. Xerostomia is one of the most common symptoms in Sjögren syndrome (SS). It is caused by a decrease in the quantity or...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-015-0798-8

    authors: Sato M,Kuroda S,Mansjur KQ,Khaliunaa G,Nagata K,Horiuchi S,Inubushi T,Yamamura Y,Azuma M,Tanaka E

    更新日期:2015-10-07 00:00:00

  • Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome.

    abstract::Genetic and environmental factors may play a role in the etiopathology of fibromyalgia syndrome (FMS) and other related syndromes. There is a high aggregation of FMS in families of FMS patients. The mode of inheritance is unknown but it is most probably polygenic. There is evidence that polymorphisms of genes in the s...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/ar2005

    authors: Buskila D,Sarzi-Puttini P

    更新日期:2006-01-01 00:00:00

  • Brain-derived neurotrophic factor and its receptor in the human and the sand rat intervertebral disc.

    abstract:INTRODUCTION:Brain-derived neurotrophic factor (BDNF) was first identified in the intervertebral disc (IVD) when its molecular upregulation was observed in sections of nucleus pulposus cultured under conditions of increased osmolarity. BDNF is now known to be involved in a number of biologic functions, including regula...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar2456

    authors: Gruber HE,Ingram JA,Hoelscher G,Zinchenko N,Norton HJ,Hanley EN Jr

    更新日期:2008-01-01 00:00:00

  • Gene expression profiles from discordant monozygotic twins suggest that molecular pathways are shared among multiple systemic autoimmune diseases.

    abstract:INTRODUCTION:The objective of this study is to determine if multiple systemic autoimmune diseases (SAID) share gene expression pathways that could provide insights into pathogenic mechanisms common to these disorders. METHODS:RNA microarray analyses (Agilent Human 1A(V2) 20K oligo arrays) were used to quantify gene ex...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3330

    authors: O'Hanlon TP,Rider LG,Gan L,Fannin R,Paules RS,Umbach DM,Weinberg CR,Shah RR,Mav D,Gourley MF,Miller FW

    更新日期:2011-04-26 00:00:00

  • CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.

    abstract:INTRODUCTION:CCAAT/enhancer-binding protein β (C/EBPβ) is a transcription factor that is activated in the synovium in rheumatoid arthritis (RA) and promotes expression of various matrix metalloproteinases. In this study, we examined whether C/EBPβ mediates the expression of receptor activator of nuclear factor-kappa-B ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-015-0532-6

    authors: Tsushima H,Okazaki K,Ishihara K,Ushijima T,Iwamoto Y

    更新日期:2015-02-17 00:00:00

  • Primary and secondary autoimmune neutropenia.

    abstract::Antineutrophil antibodies are well recognized causes of neutropenia, producing both quantitative and qualitative defects in neutrophils and increased risk for infection. In primary autoimmune neutropenia (AIN) of infancy, a moderate to severe neutropenia is the sole abnormality; it is rarely associated with serious in...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/ar1803

    authors: Capsoni F,Sarzi-Puttini P,Zanella A

    更新日期:2005-01-01 00:00:00

  • Detection of vascularity in wrist tenosynovitis: power doppler ultrasound compared with contrast-enhanced grey-scale ultrasound.

    abstract:INTRODUCTION:We sought to assess vascularity in wrist tenosynovitis by using power Doppler ultrasound (PDUS) and to compare detection of intra- and peritendinous vascularity with that of contrast-enhanced grey-scale ultrasound (CEUS). METHODS:Twenty-six tendons of 24 patients (nine men, 15 women; mean age ± SD, 54.4 ±...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3185

    authors: Klauser AS,Franz M,Arora R,Feuchtner GM,Gruber J,Schirmer M,Jaschke WR,Gabl MF

    更新日期:2010-01-01 00:00:00

  • Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease.

    abstract:BACKGROUND:Increased circulatory levels of the chemokine CXCL4 have been associated with the presence of interstitial lung disease (ILD) in an observational study of patients with systemic sclerosis (SSc). The purpose of the present study was to evaluate the relationship between baseline CXCL4 level and extent of ILD i...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s13075-016-1203-y

    authors: Volkmann ER,Tashkin DP,Roth MD,Clements PJ,Khanna D,Furst DE,Mayes M,Charles J,Tseng CH,Elashoff RM,Assassi S

    更新日期:2016-12-30 00:00:00

  • Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study.

    abstract:BACKGROUND:It is currently impossible to predict the prognosis of patients with juvenile dermatomyositis (JDM). The aim of this study was to find clinical features most strongly associated with outcome variables in JDM as a first step towards tailor-made treatment. METHODS:In a large, prospectively followed, multicent...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,多中心研究

    doi:10.1186/s13075-018-1687-8

    authors: van Dijkhuizen EHP,De Iorio M,Wedderburn LR,Deakin CT,JDRG.

    更新日期:2018-08-15 00:00:00

  • Modulating proximal cell signaling by targeting Btk ameliorates humoral autoimmunity and end-organ disease in murine lupus.

    abstract:INTRODUCTION:Systemic lupus erythematosus is a chronic autoimmune disease characterized by an abundance of autoantibodies against nuclear antigens. Bruton's tyrosine kinase (Btk) is a proximal transducer of the BCR signal that allows for B-cell activation and differentiation. Recently, selective inhibition of Btk by PC...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4086

    authors: Hutcheson J,Vanarsa K,Bashmakov A,Grewal S,Sajitharan D,Chang BY,Buggy JJ,Zhou XJ,Du Y,Satterthwaite AB,Mohan C

    更新日期:2012-11-08 00:00:00

  • Chordin knockdown enhances the osteogenic differentiation of human mesenchymal stem cells.

    abstract:INTRODUCTION:Bone morphogenetic proteins (BMPs) are critical growth factors in the osteogenic differentiation of progenitor cells during development in embryos and fracture repair in adults. Although recombinant BMPs are in use clinically, their clinical efficiency needs to be improved. The biological activities of BMP...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar2436

    authors: Kwong FN,Richardson SM,Evans CH

    更新日期:2008-01-01 00:00:00

  • Aberrantly expressed messenger RNAs and long noncoding RNAs in degenerative nucleus pulposus cells co-cultured with adipose-derived mesenchymal stem cells.

    abstract:BACKGROUND:Stem cell therapy is considered as a promising alternative to treat intervertebral disc degeneration (IDD). Extensive work had been done on identifying and comparing different types of candidate stem cells, both in vivo and in vitro. However, few studies have shed light on degenerative nucleus pulposus cells...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-018-1677-x

    authors: Han Z,Wang J,Gao L,Wang Q,Wu J

    更新日期:2018-08-16 00:00:00

  • The autoimmune tautology.

    abstract::Although autoimmune diseases exhibit contrasting epidemiological features, pathology, and clinical manifestations, three lines of evidence demonstrate that these diseases share similar immunogenetic mechanisms (that is, autoimmune tautology). First, clinical evidence highlights the co-occurrence of distinct autoimmune...

    journal_title:Arthritis research & therapy

    pub_type: 评论,社论,评审

    doi:10.1186/ar3175

    authors: Anaya JM

    更新日期:2010-01-01 00:00:00

  • Stratifying primary Sjögren's syndrome: killers in the balance?

    abstract::The article by Seror et al. in Arthritis Research & Therapy reports data from the 15 French patients in the open-label BELISS (Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome, NCT01160666) study of belimumab in primary Sjögren's syndrome. The study identifies that higher baseline levels of...

    journal_title:Arthritis research & therapy

    pub_type: 社论

    doi:10.1186/s13075-015-0878-9

    authors: Bowman SJ,Fisher BA

    更新日期:2015-12-07 00:00:00

  • Association of large intergenic noncoding RNA expression with disease activity and organ damage in systemic lupus erythematosus.

    abstract:INTRODUCTION:Despite growing evidence that large intergenic noncoding RNAs (lincRNAs) can regulate gene expression and widely take part in normal physiological and disease conditions, our knowledge of systemic lupus erythematosus (SLE)-related lincRNAs remains limited. The aim of this study was to detect the levels of ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-015-0632-3

    authors: Wu Y,Zhang F,Ma J,Zhang X,Wu L,Qu B,Xia S,Chen S,Tang Y,Shen N

    更新日期:2015-05-21 00:00:00

  • Anti-Sa antibodies: prognostic and pathogenetic significance to rheumatoid arthritis.

    abstract::Anti-Sa antibodies are detected in the serum of 20-47% of patients with rheumatoid arthritis. These antibodies have a high degree of specificity for the disease, and appear to identify a subset of early rheumatoid arthritis patients destined to have aggressive and destructive disease. It has recently been confirmed th...

    journal_title:Arthritis research & therapy

    pub_type: 评论,杂志文章,评审

    doi:10.1186/ar1171

    authors: El-Gabalawy HS,Wilkins JA

    更新日期:2004-01-01 00:00:00

  • Interleukin-17A- or tumor necrosis factor α-mediated increase in proliferation of T cells cocultured with synovium-derived mesenchymal stem cells in rheumatoid arthritis.

    abstract:INTRODUCTION:Mesenchymal stem cells (MSCs) represent promising applications in rheumatoid arthritis (RA). However, the inflammatory niche in the RA synovium could adversely affect MSC function. This study was designed to investigate biologic and immunologic properties of synovium-derived MSCs (SMSCs) in RA, with partic...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4355

    authors: Zhang Z,Ding Y,Li W,Song B,Yang R

    更新日期:2013-10-29 00:00:00

  • Prognostic factors for progression of clinical osteoarthritis of the knee: a systematic review of observational studies.

    abstract:INTRODUCTION:We performed a systematic review of prognostic factors for the progression of symptomatic knee osteoarthritis (OA), defined as increase in pain, decline in physical function or total joint replacement. METHOD:We searched for available observational studies up to January 2015 in Medline and Embase accordin...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/s13075-015-0670-x

    authors: Bastick AN,Runhaar J,Belo JN,Bierma-Zeinstra SM

    更新日期:2015-06-08 00:00:00

  • Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study.

    abstract:INTRODUCTION:The metabolic syndrome (MetS) may contribute to the excess cardiovascular burden observed in rheumatoid arthritis (RA). The prevalence and associations of the MetS in RA remain uncertain: systemic inflammation and anti-rheumatic therapy may contribute. Methotrexate (MTX) use has recently been linked to a r...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar2765

    authors: Toms TE,Panoulas VF,John H,Douglas KM,Kitas GD

    更新日期:2009-01-01 00:00:00

  • Randomized controlled studies on the efficacy of antiarthritic agents in inhibiting cartilage degeneration and pain associated with progression of osteoarthritis in the rat.

    abstract:BACKGROUND:As an initial step in the development of a local therapeutic to treat osteoarthritis (OA), a number of agents were tested for their ability to block activation of inflammation through nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB), subchondral bone changes through receptor activator of nu...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-016-0921-5

    authors: TenBroek EM,Yunker L,Nies MF,Bendele AM

    更新日期:2016-01-21 00:00:00

  • CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis.

    abstract::The accumulation of T cells in the synovial membrane is the crucial step in the pathophysiology of the inflammatory processes characterizing juvenile idiopathic arthritis (JIA). In this study, we evaluated the expression and the pathogenetic role in oligoarticular JIA of a CXC chemokine involved in the directional mig...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar1481

    authors: Martini G,Zulian F,Calabrese F,Bortoli M,Facco M,Cabrelle A,Valente M,Zacchello F,Agostini C

    更新日期:2005-01-01 00:00:00

  • The new era of autoimmune disease research.

    abstract::Recent genome-wide association studies have advanced our understanding of genetic factors that underlie systemic lupus erythematosus (SLE), a multifactorial autoimmune disease characterized by various clinical manifestations. SLE also has an environmental component, which can trigger or exacerbate the disease. Despite...

    journal_title:Arthritis research & therapy

    pub_type: 评论,社论

    doi:10.1186/ar3335

    authors: Koike T

    更新日期:2011-05-31 00:00:00

  • Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy.

    abstract:INTRODUCTION:Tumor necrosis factor (TNF) antagonists reduce the signs and symptoms of spondyloarthritides, including ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Our objective was to evaluate the effectiveness and safety of adalimumab, 40 mg every other week, for patients with AS or PsA and prior treatmen...

    journal_title:Arthritis research & therapy

    pub_type: 临床试验,杂志文章

    doi:10.1186/ar3054

    authors: Rudwaleit M,Van den Bosch F,Kron M,Kary S,Kupper H

    更新日期:2010-01-01 00:00:00

  • The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.

    abstract:INTRODUCTION:Pulmonary arterial hypertension (PAH) is a major cause of mortality in systemic sclerosis (SSc). Screening guidelines for PAH recommend multiple investigations, including annual echocardiography, which together have low specificity and may not be cost-effective. We sought to evaluate the predictive accurac...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4383

    authors: Thakkar V,Stevens W,Prior D,Youssef P,Liew D,Gabbay E,Roddy J,Walker JG,Zochling J,Sahhar J,Nash P,Lester S,Rischmueller M,Proudman SM,Nikpour M

    更新日期:2013-01-01 00:00:00